Recent studies indicate that the interplay of specific cytokines, including TNF and interferon-gamma (IFN-γ), might trigger PANoptosis in neoplastic cells, potentially resulting in decreased tumor size in preclinical models [102,103]. The gene discussed is IFNG; the disease is neoplasm.